Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Cigna Group
Bear Case (25th pct.)
38.7% vs price
Base Case (Median)
70.4% vs price
Bull Case (75th pct.)
93.9% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $470.85 | 74.0% | High (40%) |
| PE Comparable | $542.41 | 100.5% | Medium (25%) |
| Graham Number | $293.15 | 8.4% | Medium (40%) |
| EV/EBITDA | $349.87 | 29.3% | Medium (20%) |
| EV/FCF | $599.94 | 121.8% | Medium (20%) |
| Earnings Power Value | $451.34 | 66.8% | Medium (50%) |
Based on 6 out of 7 methods, CI appears undervalued at the current price of $270.53. The base case fair value of $461.10 implies 70.4% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.